171 related articles for article (PubMed ID: 25031446)
21. Fecal host biomarkers predicting severity of Clostridioides difficile infection.
Golizeh M; Winter K; Roussel L; Landekic M; Langelier M; Loo VG; Ndao M; Vinh DC
JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33232301
[TBL] [Abstract][Full Text] [Related]
22. Faecal microbiota transplantation for
Terveer EM; Vendrik KE; Ooijevaar RE; Lingen EV; Boeije-Koppenol E; Nood EV; Goorhuis A; Bauer MP; van Beurden YH; Dijkgraaf MG; Mulder CJ; Vandenbroucke-Grauls CM; Seegers JF; van Prehn J; Verspaget HW; Kuijper EJ; Keller JJ
United European Gastroenterol J; 2020 Dec; 8(10):1236-1247. PubMed ID: 32990503
[TBL] [Abstract][Full Text] [Related]
23. Loop-mediated isothermal amplification compared to real-time PCR and enzyme immunoassay for toxigenic Clostridium difficile detection.
Boyanton BL; Sural P; Loomis CR; Pesta C; Gonzalez-Krellwitz L; Robinson-Dunn B; Riska P
J Clin Microbiol; 2012 Mar; 50(3):640-5. PubMed ID: 22189114
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of cycloserine-cefoxitin fructose agar (CCFA), CCFA with horse blood and taurocholate, and cycloserine-cefoxitin mannitol broth with taurocholate and lysozyme for recovery of Clostridium difficile isolates from fecal samples.
Tyrrell KL; Citron DM; Leoncio ES; Merriam CV; Goldstein EJ
J Clin Microbiol; 2013 Sep; 51(9):3094-6. PubMed ID: 23804392
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the Cepheid Xpert Clostridium difficile Epi assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital.
Babady NE; Stiles J; Ruggiero P; Khosa P; Huang D; Shuptar S; Kamboj M; Kiehn TE
J Clin Microbiol; 2010 Dec; 48(12):4519-24. PubMed ID: 20943860
[TBL] [Abstract][Full Text] [Related]
26. The nose knows not: poor predictive value of stool sample odor for detection of Clostridium difficile.
Rao K; Berland D; Young C; Walk ST; Newton DW
Clin Infect Dis; 2013 Feb; 56(4):615-6. PubMed ID: 23166192
[No Abstract] [Full Text] [Related]
27. Real-time cellular analysis coupled with a specimen enrichment accurately detects and quantifies Clostridium difficile toxins in stool.
Huang B; Jin D; Zhang J; Sun JY; Wang X; Stiles J; Xu X; Kamboj M; Babady NE; Tang YW
J Clin Microbiol; 2014 Apr; 52(4):1105-11. PubMed ID: 24452160
[TBL] [Abstract][Full Text] [Related]
28. Rapid, accurate, and on-site detection of C. difficile in stool samples.
Bomers MK; Menke FP; Savage RS; Vandenbroucke-Grauls CM; van Agtmael MA; Covington JA; Smulders YM
Am J Gastroenterol; 2015 Apr; 110(4):588-94. PubMed ID: 25823766
[TBL] [Abstract][Full Text] [Related]
29. Modified multiple-locus variable-number tandem-repeat analysis for rapid identification and typing of Clostridium difficile during institutional outbreaks.
Broukhanski G; Low DE; Pillai DR
J Clin Microbiol; 2011 May; 49(5):1983-6. PubMed ID: 21411590
[TBL] [Abstract][Full Text] [Related]
30. Multicenter clinical evaluation of the portrait toxigenic C. difficile assay for detection of toxigenic Clostridium difficile strains in clinical stool specimens.
Buchan BW; Mackey TL; Daly JA; Alger G; Denys GA; Peterson LR; Kehl SC; Ledeboer NA
J Clin Microbiol; 2012 Dec; 50(12):3932-6. PubMed ID: 23015667
[TBL] [Abstract][Full Text] [Related]
31. Clinical comparison of Simplexa universal direct and BD GeneOhm tests for detection of toxigenic Clostridium difficile in stool samples.
Nolte FS; Ribeiro-Nesbitt DG
J Clin Microbiol; 2014 Jan; 52(1):281-2. PubMed ID: 24197886
[TBL] [Abstract][Full Text] [Related]
32. A cost-effective approach for detection of toxigenic Clostridium difficile: toxigenic culture using ChromID Clostridium difficile agar.
Luk S; To WK; Ng TK; Hui WT; Lee WK; Lau F; Ching AM
J Clin Microbiol; 2014 Feb; 52(2):671-3. PubMed ID: 24478510
[TBL] [Abstract][Full Text] [Related]
33. Clostridium difficile mixed infection and reinfection.
Eyre DW; Walker AS; Griffiths D; Wilcox MH; Wyllie DH; Dingle KE; Crook DW; Peto TE
J Clin Microbiol; 2012 Jan; 50(1):142-4. PubMed ID: 22075589
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples.
Le Guern R; Herwegh S; Grandbastien B; Courcol R; Wallet F
J Clin Microbiol; 2012 Sep; 50(9):3089-90. PubMed ID: 22760042
[TBL] [Abstract][Full Text] [Related]
35. Specific detection of toxigenic strains of Clostridium difficile in stool specimens.
Gumerlock PH; Tang YJ; Weiss JB; Silva J
J Clin Microbiol; 1993 Mar; 31(3):507-11. PubMed ID: 8458943
[TBL] [Abstract][Full Text] [Related]
36. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
Humphries RM; Uslan DZ; Rubin Z
J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection.
Bruins MJ; Verbeek E; Wallinga JA; Bruijnesteijn van Coppenraet LE; Kuijper EJ; Bloembergen P
Eur J Clin Microbiol Infect Dis; 2012 Nov; 31(11):3035-9. PubMed ID: 22706512
[TBL] [Abstract][Full Text] [Related]
38. Prevalence and risk factors for asymptomatic Clostridium difficile carriage.
Alasmari F; Seiler SM; Hink T; Burnham CA; Dubberke ER
Clin Infect Dis; 2014 Jul; 59(2):216-22. PubMed ID: 24755858
[TBL] [Abstract][Full Text] [Related]
39. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms.
Novak-Weekley SM; Marlowe EM; Miller JM; Cumpio J; Nomura JH; Vance PH; Weissfeld A
J Clin Microbiol; 2010 Mar; 48(3):889-93. PubMed ID: 20071552
[TBL] [Abstract][Full Text] [Related]
40. Toxigenic Clostridium difficile colonization among hospitalised adults; risk factors and impact on survival.
Behar L; Chadwick D; Dunne A; Jones CI; Proctor C; Rajkumar C; Sharratt P; Stanley P; Whiley A; Wilks M; Llewelyn MJ
J Infect; 2017 Jul; 75(1):20-25. PubMed ID: 28435086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
